Silagy Andrew, Zabor Emily, Mano Roy, DiNatale Renzo, Marcon Julian, Kashani Mahyar, Blum Kyle, Reznik Eduard, Jaimes Edgar, Coleman Jonathan, Ari Hakimi A, Russo Paul
Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
Department of Surgery, University of Melbourne, Austin Hospital, Melbourne, Australia.
Can Urol Assoc J. 2021 Feb;15(2):E103-E109. doi: 10.5489/cuaj.6485.
We evaluated the trajectory of estimated glomerular filtration rate (eGFR) after kidney surgery in patients with kidney cancer and chronic kidney disease (CKD).
We identified 1204 consecutive patients in our institutional database with preoperative CKD undergoing partial or radical nephrectomy from 1998-2016. Postoperative eGFR was tracked, with patients censored when receiving dialysis or kidney transplantation. A multivariable mixed-effects models assessed associations between preoperative baseline patient and tumor characteristics, and longitudinal eGFR. The Kaplan-Meier method and multivariable Cox regression were used to estimate overall survival, cancer-specific survival, and cumulative incidence of dialysis.
Preoperatively, 892 (74.1%), 271 (22.5%), and 41 (3.4%) patients had CKD stage 3a, 3b, and 4/5, respectively. There were 55 patients dialyzed and 355 deaths (99 from kidney cancer). Median followup was 8.1 years, with 25 781 postoperative eGFR measurements. Factors associated with decreasing eGFR postoperatively included radical nephrectomy, male gender, older age, increased body mass index (BMI), and cardiovascular risk factors. We observed a significant interaction effect between time from surgery and preoperative CKD stage: the eGFR of stage 3a patients improved, while stage ≥3b declined (p<0.001). The two-year and five-year cumulative incidence of dialysis was 1.8% (1.1-2.6%) and 3.1% (2.2-4.2%), respectively. The cumulative incidence of dialysis, with death as a competing event, significantly differed by preoperative CKD stage.
Preoperative CKD stage ≥3b is independently associated with a higher risk of declining renal function, dialysis, and mortality. With careful selection, patients with preoperative CKD withstand kidney surgery with low rates of dialysis.
我们评估了肾癌合并慢性肾脏病(CKD)患者肾脏手术后估计肾小球滤过率(eGFR)的变化轨迹。
我们在机构数据库中识别出1998年至2016年间1204例接受部分或根治性肾切除术且术前患有CKD的连续患者。追踪术后eGFR,患者接受透析或肾移植时进行截尾。多变量混合效应模型评估术前基线患者和肿瘤特征与纵向eGFR之间的关联。采用Kaplan-Meier法和多变量Cox回归估计总生存期、癌症特异性生存期和透析累积发生率。
术前,分别有892例(74.1%)、271例(22.5%)和41例(3.4%)患者处于CKD 3a期、3b期和4/5期。有55例患者接受透析,355例死亡(99例死于肾癌)。中位随访时间为8.1年,术后有25781次eGFR测量值。术后eGFR下降相关因素包括根治性肾切除术、男性、年龄较大、体重指数(BMI)增加和心血管危险因素。我们观察到手术时间与术前CKD分期之间存在显著的交互作用:3a期患者的eGFR有所改善,而≥3b期患者的eGFR下降(p<0.001)。透析的两年和五年累积发生率分别为1.8%(1.1-2.6%)和3.1%(2.2-4.2%)。以死亡作为竞争事件,透析累积发生率在术前CKD分期之间存在显著差异。
术前CKD≥3b期与肾功能下降、透析和死亡风险较高独立相关。经过仔细筛选,术前患有CKD的患者接受肾脏手术的透析率较低。